Date Hour Room Track
04th December,2018 9:30-11:00 am Track 1

Companies are now using machine learning in highly specific ways to streamline and improve many day-to-day biomedical research tasks. The use of AI has shifted from generalist tasks to purpose-built tools with numerous applications to speed up drug discovery at all the different research stages. The panel will address some of the uses of AI, ultimately potentially cutting R&D costs by aggregating and synthesising information, repurposing existing drugs, generating and validating novel drug candidates, designing drugs and preclinical experiments, etc.

Emmet Browne - NURITAS
Noor Shaker - GTN LTD
Pascal Sempe - IBM
Melanie Senior - INFORMA

Continue your tour